These aberrations predominated in astrocytomas (TP53: 87.2%; ATRX: 68.6%), whereas oligodendrogliomas showed minimal TP53 (9.4%) and ATRX (3.8%) alterations. Here, TP53 is linked to oligodendroglioma.